PDCD1 and non-small cell lung carcinoma: For instance, next-generation sequencing of plasma EV-miRNAs from advanced NSCLC patients treated with or without PD-1/PD-L1 inhibitors revealed a significant correlation between EV-miRNAs and anti-PD-1/PD-L1 treatment response [167–169].